<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362353">
  <stage>Registered</stage>
  <submitdate>9/04/2012</submitdate>
  <approvaldate>12/04/2012</approvaldate>
  <actrnumber>ACTRN12612000408886</actrnumber>
  <trial_identification>
    <studytitle>comparison of benefit of tramadol-only treatment and tramadol+gabapentin treatment in patient with lumbar disc herniation after epidural steroid injection</studytitle>
    <scientifictitle>a clinical trial to compare the effect of tramadol only treatment with tramadol + gabapentin treatment on the clinical course, serotonin level, and inflammatory response for patients with lumbar disc herniation after epidural steroid injection</scientifictitle>
    <utrn>u1111-1129-8263</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Lumbar disc herniation</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>All the patients received a single dose steroid and local anesthesia mixture epidurally via the lumbar approach In study group (Group T, (Tramadol, n=20). Injection dose was adjusted to 10 ml from triamcinolone acetonide, and 0.125% bupivacaine mixture. Oral dose of 100 mg/day tramadol was added to the treatment of patients in group T during study period (15 days).</interventions>
    <comparator>All the patients received a single dose steroid and local anesthesia mixture epidurally via the lumbar approach In comparator group (Group TG, (Tramadol+Gabapentin, n=20). Injection dose was adjusted to 10 ml from triamcinolone acetonide, and 0.125% bupivacaine mixture. Oral dose of 100 mg/day tramadol + 1800 mg/day gabapentin was added to the treatment of patients in group TG during study period (15 days).</comparator>
    <control>Active</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Clinical improvement as asssesed by Visual Analogous Scale (VAS), Oswestry Disability Index (ODI) and Straigt Leg Elevation Test (SLET).</outcome>
      <timepoint>at 15 days after starting to use drugs</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Inflammatory response  as assesed by Leucocyte (WBC), erythrocyte sedimentation rate (ESR), C Reactive Protein (CRP) and urine serotonin levels.</outcome>
      <timepoint>at 15 days after starting to use drugs</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Herniated lumbar disc, epidural steroid injection</inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>55</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>bilateral root pressure findings, neurologic deficit, previous lumbar vertebral surgery history, serious cardiac, pulmonary, hematological, gastrointestinal, and liver or kidney disease, glaucoma, urinary retention, statin group drug usage, hormone replacement therapy, and known allergy to the study drugs</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/09/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Mustafa ISIK</primarysponsorname>
    <primarysponsoraddress>University of Gaziantep, Faculty of Medicine, Orthopedic department. Universite bulvari Sahinbey Hastanesi Ortopedi Klinigi.  27100 / Gaziantep</primarysponsoraddress>
    <primarysponsorcountry>Turkey</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The aim of this study was to compare the effects of tramadol-only treatment and tramadol+gabapentin treatment on clinical course, serotonin level and inflammatory response in patients with lumbar disc herniation after epidural steroid injection</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Ethics Committee of University of Gaziantep / Turkey</ethicname>
      <ethicaddress>Universite bulvari, Sahinbey Hastanesi Ortopedi poliklinigi.  27100 / Gaziantep</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Turkey</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Mustafa ISIK</name>
      <address>University of Gaziantep, Faculty of Medicine, Departmant of Orthopedic.

Gaziantep Universitesi Tip Fakultesi Ortopedi ve Travmatoloji A.D.  27100 /  Gaziantep / Turkiye</address>
      <phone>+90 533 6361796</phone>
      <fax />
      <email>drmustafaisik@yahoo.com</email>
      <country>Turkey</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Mustafa ISIK</name>
      <address>University of Gaziantep, Faculty of Medicine, Departmant of Orthopedic.

Gaziantep Universitesi Tip Fakultesi Ortopedi ve Travmatoloji A.D.  27100 /  Gaziantep / Turkiye</address>
      <phone>+90 533 6361796</phone>
      <fax />
      <email>drmustafaisik@yahoo.com</email>
      <country>Turkey</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>